BIOREM Inc.
BIRMF
$2.58
$0.083.23%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.43M | 24.94M | 27.68M | 26.20M | 27.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.43M | 24.94M | 27.68M | 26.20M | 27.29M |
| Cost of Revenue | 21.26M | 18.88M | 20.24M | 19.39M | 19.94M |
| Gross Profit | 9.18M | 6.06M | 7.44M | 6.81M | 7.35M |
| SG&A Expenses | 4.41M | 3.81M | 4.16M | 3.92M | 4.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 0.00 | -81.90K | -76.50K | -76.50K | -76.50K |
| Total Operating Expenses | 25.70M | 22.67M | 24.36M | 23.27M | 24.00M |
| Operating Income | 4.73M | 2.27M | 3.32M | 2.93M | 3.30M |
| Income Before Tax | 4.56M | 2.08M | 3.13M | 2.73M | 3.04M |
| Income Tax Expenses | 1.09M | 555.60K | 832.10K | 727.50K | 807.90K |
| Earnings from Continuing Operations | 3.47 | 1.53 | 2.29 | 2.00 | 2.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.47M | 1.53M | 2.29M | 2.00M | 2.23M |
| EBIT | 4.73M | 2.27M | 3.32M | 2.93M | 3.30M |
| EBITDA | 5.06M | 2.59M | 3.68M | 3.27M | 3.59M |
| EPS Basic | 0.23 | 0.10 | 0.14 | 0.13 | 0.14 |
| Normalized Basic EPS | 0.19 | 0.08 | 0.12 | 0.11 | 0.12 |
| EPS Diluted | 0.20 | 0.08 | 0.12 | 0.11 | 0.12 |
| Normalized Diluted EPS | 0.16 | 0.07 | 0.10 | 0.09 | 0.10 |
| Average Basic Shares Outstanding | 65.49M | 66.28M | 66.07M | 65.74M | 62.80M |
| Average Diluted Shares Outstanding | 72.55M | 74.75M | 74.76M | 74.68M | 74.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |